JavidFaziliMDFACP, FAASLD

PubMed

• From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases.
  Landon L Moore, Dongfeng Qu, Sripathi Sureban, Stephanie Mitchell, Kamille Pitts
  International Journal of Molecular Sciences. 2024-06-12
• 7 citations
  Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism.
  Naushad Ali, Charles B. Nguyen, Parthasarathy Chandrakesan, Roman F. Wolf, Dongfeng Qu
  Scientific Reports. 2020-06-29
• 18 citations
  Treatment Outcomes of Hepatitis C-Infected Patients in Specialty Clinic vs. Primary Care Physician Clinic: A Comparative Analysis
  Taseen Syed, Muhammad H. Bashir, Samid M. Farooqui, Allshine Chen, Sixia Chen
  Gastroenterology Research and Practice. 2019-06-04

Journal Articles

• Mystery of Hepatitis E Virus: Recent Advances in Its Diagnosis and Management  
  Aftab Ahmed, Ijlal Akbar Ali, Hira Ghazal, Javid Fazili, Salman Nusrat, Intl J of Hepatology, 1/1/2015
• A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients  
  T. Bader, L.D. Hughes, J. Fazili, B. Frost, M. Dunnam, A. Gonterman, M. Madhoun and C.E. Aston, Journal of Viral Hepatitis, 1/1/2013
• Outcome of a Hepatitis C Outbreak among Patients in a Pain Management Clinic  
  Fazili J, Mallonee S, Tierney WM, Bader TF, Sachdev AK, Bird PC, Schmidt RD, Mesiya SA, Lackey CL, Digestive Diseases and Sciences, 1/1/2010
• Fluvastatin inhibitis hepatitis C replication in humans  
  Bader T, Fazili J, Madhoun M, Aston C, Hughes D, Rizvi S, Seres K, Hasan M, Am J Gastroenterol, 1/1/2008
• Randomized controlled trial of Iamivudine to treat acute hepatitis B (Letter to the Editor)  
  Javid Fazili, Teddy F Bader, William Tierney, Hepatology, 1/1/2007
• Remission of natural -killer cell lymphoma of the liver with anti-hepatitis C therapy  
  Armor JF, Fazili J, Toubia N, Kern W, Kamble R, Kharfan-Dabaja MA, Am J Hematol, 1/1/2005
• The proximal shift in the distribution of colon cancer is independent of age and gender  
  Frank Friedenberg, Agel Fernandez, Barbara Sorondo, Javid Fazili, Leonard Braitman, The Journal of Applied Research, 1/1/2001
• Squamous cell carcinoma of the pancreas  
  Neil Louwrens, Frank Friedenberg, Nayere Zaeri, Javid Fazili, Richard Greenberg, William Tester, and Leon Rubinstain, GI Cancer, 1/1/1999
• Join now to see all

Books/Book Chapters

• Practical Manual of Abdominal Transplantation 
  Chapter: Pre-transplant evaluation of liver. 
  Javid Fazili, Vivek Kaul, Keneth D. Rothstein, and Santiago J. Munoz2002

Abstracts/Posters

• Expecting the Unexpected: Black Cohosh-induced Hepatotoxicity Leading to Early Cirrhosis.
  Khadija Chaudrey, Muhammad S. Khan, Javid Fazili, ACG, 1/1/2013
• Early Results of a Phase II RCT Trial of Adding Fluvastatin to Peginterferon Alfa 2a and Ribavirin.
  Ted Bader, Diane Hughes, Javid Fazili, Monica Dunnam, Joe Cardello, and Michael Bronze, DDW, 1/1/2010
• The impact of Filgrastim and Epotein use on sustained viral response (SVR) rates in Hepatitis C patients treated with Peg-Interferon and Ribavirin.
  Waqar Ahmad, Diane Hughes, Monica Dunnam, Qaiser Khan and, Javid Fazili, ACG, 1/1/2008
• Hepatocellular Carcinoma in a Patient with Hepatitis C in the Absence of Cirrhosis.
  Javid Fazili MD, Mohammad Madhoun MD, Larry Pennington MD, Am J Gastroenterol, 1/1/2007
• Statins Improve ALT Values in Chronic Hepatitis C Patients with Abnormal Values.
  Ted Bader, Mohammad Madhoun, Syed Rizvi, Ken Seres, and Javid Fazili, DDW, 1/1/2007
• Outcome of an Acute Hepatitis C Outbreak among patients in a Pain Management Clinic.
  Arun K Sachdev, Sue Mallonee, Charles Lackey, Robert D Schmidt, Teddy Bader, Philip C Bird, Sikander A Mesiya, William M Tierney and Javid Fazili (principal investigator), DDW, 1/1/2006
• Imatinib Mesylate (Gleevec) Induced Hepatitis.
  Madhavi Rudraraju, M.D., Nadeem Chaudary, M.D., and Javid Fazili, M.D., Scientific Meeting, American college of Gastroenterology, 1/28/2005
• The effect of amantadine on sustained virological response when added to standard therapy in non-one genotype hepatitis C patients.
  Arun Sachdev, Javid Fazili, and Sikander Mesiya, DDW, 1/1/2004
• Validation of a model to diagnose cirrhosis in patients with chronic hepatitis C.
  Ali Siddiqui, Javid Fazili (principal investigation), and Sikandar Mesiya, 68th annual scientific meeting, American College of Gastroenterology, 1/1/2003
• Reversal of advanced liver fibrosis with phlebotomy in a patient with porphyria cutanea tarda and hepatitis C.
  Muhammad K. Hasan, Ali Siddiqui, Sikander Mesiya, Javid Fazili, Jan Pitha, and Michale Talbeat, 68th annual scientific meeting, American College of Gastroenterology, 1/1/2003
• Futility of autoimmune serologies in the work-up of patients with chronic hepatitis C.
  Ali Siddiqui, Muhammad K. Hasan, Bhagwat Patel, Javid Fazili, and Sikandar Mesiya, University of Oklahoma Health Sciences Center and Veterans Affairs Medical center Ok..., Hepatology, 1/1/2002
• The prevalence of hepatitis C genotypes in U.S. Veterans in the State of Oklahoma.
  Bhagwat Patel, Ali Siddiqui, Javid Fazili, and Sikandar Mesiya, Hepatology, 1/1/2002
• Obese and Morbidly obese liver transplant recipients fare as well as non-obese recipients.
  Kenneth D. Rothstein, Vivek kaul, Frank K. Friedenberg, Leonard Braitman, Javid Fazili, Carol Lamb, David J. Reich Cosme Manzarbetia, and Santiago Munoz, DDW meeting 2000, Gastroenterology, 1/1/2000
• Helicobacter Pylori associated Intestinal Metaplasia and dysplasia are prevalent in Asian-Americans.
  Gary M. Levine, Nayere Zaeri, Tawe Tanvetyanon, Frank Fridenberg, Arthur Geller, Javid Fazili, Vivek Kaul, Huyen Yran, young Nam Kirm, Gastroenterology, 1/1/2000
• The changing distribution of Colon cancer.
  Friedenberg F, Javid Fazili, and Angel Fernandez, National ACP meeting, 1/1/2000
• Endoscopic Injection sclerotherapy for bleeding esophageal varices in patients with extra hepatic portal hypertension.
  Javid Fazili and M.S. Khuroo, Institute of Medical Sciences, Soura, Srinagar, Kashmir, India, 1/1/1994
• Join now to see all

Lectures

• Hepatitis C Management Update. 
  Oklahoma Health Sciences Center - 1/15/2014
• Hepatitis E: New Insights to Epidemiology and Clinical Manifestations. 
  Oklahoma Health Sciences Center, Department of Medicine - 1/5/2014
• Hepatitis C, Interferon Free Treatment Options (The Beginning of a New Era?). 
  Oklahoma Health Sciences Center - 1/20/2013
• Update on Treatment of Hepatitis B: Managing Hepatitis B in Pregnancy and in Patients on Chemotherapy. 
  Oklahoma Health Sciences Center - 1/27/2011
• Hepatitis B and C, an update. 
  Oklahoma Health Sciences Center - 1/11/2006
• Treatment of Viral Hepatitis B and C. 
  Oklahoma City, OK - 1/1/2006
• An update on Viral Hepatitis. 
  1/16/2005
• Management of Hepatitis B- an update. 
  Department of Medicine, Oklahoma Health Sciences Center - 1/1/2003
• Viral Hepatitis. 
  Oklahoma City, OK - 1/1/2002
• Indication for liver transplantation. 
  University of Oklahoma Health Sciences Center - 1/1/2000
• How Gastroenterologist communicate results of endoscopies to patients. 
  1/1/1999
• Join now to see all

Other

• Endoscopic injection sclerotherapy for bleeding esophageal varices in patients with extra hepatic portal hypertension. 
  Javid Fazili, M.D.
  1/1/1992